Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; Comparison with drugs used in ADHD

Neuropsychopharmacology

Volumn 39, Issue 11, 2014, Pages 2622-2632

  Davies, William ^a   Humby, Trevor ^a   Trent, Simon ^a   Eddy, Jessica B ^a   Ojarikre, Obah A ^b   Wilkinson, Lawrence S ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4-METHYLCOUMARIN 7-O-SULFAMATE; ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL STIMULANT AGENT; COUMARIN DERIVATIVE; ENZYME INHIBITOR; METHYLPHENIDATE; PRASTERONE SULFATE; PROPYLAMINE; STERYL SULFATASE; SULFONAMIDE;

ANIMAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODEL; DRUG EFFECTS; GENETICS; INHIBITION (PSYCHOLOGY); MALE; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; TRANSGENIC MOUSE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ATOMOXETINE HYDROCHLORIDE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; COUMARINS; DEHYDROEPIANDROSTERONE SULFATE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; MICE, TRANSGENIC; NEUROPSYCHOLOGICAL TESTS; PROPYLAMINES; PSYCHOMOTOR PERFORMANCE; STERYL-SULFATASE; SULFONAMIDES;

EID: 84939871420     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.115     Document Type: Article

References (56)

1. Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003). Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54: 1465-1468.
2. Bari A, Robbins TW (2013). Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD. Psychopharmacology 230: 89-111.
3. Blondeau C, Dellu-Hagedorn F (2007). Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 61: 1340-1350.
4. Bonelli RM, Cummings JL (2007). Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci 9: 141-151.
5. Brewer JA, Potenza MN (2008). The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 75: 63-75.
6. Brookes KJ, Hawi Z, Kirley A, Barry E, Gill M, Kent L (2008). Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B: 1531-1535.
7. Brookes KJ, Hawi Z, Park J, Scott S, Gill M, Kent L (2010). Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression. Am J Med Genet B Neuropsychiatr Genet 153B: 1417-1424.
8. Carter JD, Farrow M, Silberstein RB, Stough C, Tucker A, Pipingas A (2003). Assessing inhibitory control: a revised approach to the stop signal task. J Atten Disord 6: 153-161.
9. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006). Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311: 861-863.
10. Compagnone NA, Salido E, Shapiro LJ, Mellon SH (1997). Expression of steroid sulfatase during embryogenesis. Endocrinology 138: 4768-4773.
11. Crosbie J, Perusse D, Barr CL, Schachar RJ (2008). Validating psychiatric endophenotypes: inhibitory control and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 32: 40-55.
12. Dalley JW, Roiser JP (2012). Dopamine, serotonin and impulsivity. Neuroscience 215: 42-58.
13. Davies W (2012). Does steroid sulfatase deficiency influence postpartum psychosis risk? Trends Mol Med 18: 256-262.
14. Davies W, Humby T, Isles AR, Burgoyne PS, Wilkinson LS (2007). X-monosomy effects on visuospatial attention in mice: a candidate gene and implications for Turner syndrome and attention deficit hyperactivity disorder. Biol Psychiatry 61: 1351-1360.
15. Davies W, Humby T, Kong W, Otter T, Burgoyne PS, Wilkinson LS (2009). Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biol Psychiatry 66: 360-367.
16. DeVito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC et al (2009). Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) 202: 531-539.
17. Eagle DM, Robbins TW (2003). Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task. Behav Brain Res 146: 131-144.
18. Eagle DM, Tufft MR, Goodchild HL, Robbins TW (2007). Differential effects of modafinil and methylphenidate on stopsignal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 192: 193-206.
19. Economidou D, Theobald DE, Robbins TW, Everitt BJ, Dalley JW (2012). Norepinephrine and dopamine modulate impulsivity on the five-choice serial reaction time task through opponent actions in the shell and core sub-regions of the nucleus accumbens. Neuropsychopharmacology 37: 2057-2066.
20. Grimley Evans J, Malouf R, Huppert F, van Niekerk JK (2006). Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database Syst Rev 4: CD006221.
21. Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K (2013). Metaanalysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 70: 185-198.
22. Holden C (2005). Sex and the suffering brain. Science 308: 1574.
23. Humby T, Eddy JB, Good MA, Reichelt AC, Wilkinson LS (2013). A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism. Neuropsychopharmacology 38: 2150-2159.
24. Humby T, Wilkinson LS (2011). Assaying dissociable elements of behavioural inhibition and impulsivity: translational utility of animal models. Curr Opin Pharmacol 11: 534-539.
25. Inglis WL, Olmstead MC, Robbins TW (2001). Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions. Behav Brain Res 123: 117-131.
26. Kent L, Emerton J, Bhadravathi V, Weisblatt E, Pasco G, Willatt LR et al (2008). X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J Med Genet 45: 519-524.
27. Logan GD (1994). On the ability to inhibit thought and action: a users' guide to the stop signal paradigm. In: DC TH (ed). Inhibitory Processes in Attention, Memory and Language. Academic Press: San Diego, pp 189-239.
28. Logan GD, Cowan WB, Davis KA (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10: 276-291.
29. Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 30: 65-91.
30. McKinney M, Jacksonville MC (2005). Brain cholinergic vulnerability: Relevance to behavior and disease. Biochem Pharmacol 70: 1115-1124.
31. Nicolas LB, Fry JP (2007). The steroid sulfatase inhibitor COUMATE attenuates rather than enhances access of dehydroepiandrosterone sulfate to the brain in the mouse. Brain Res 1174: 92-96.
32. Nicolas LB, Pinoteau W, Papot S, Routier S, Guillaumet G, Mortaud S (2001). Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Res 922: 216-222.
33. Perumal AS, Robins E (1973). Regional and subcellular distribution of aryl-and steroid sulfatases in brain. Brain Res 59: 349-358.
34. Pezze MA, Dalley JW, Robbins TW (2007). Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology 32: 273-283.
35. Purohit A, Foster PA (2012). Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers. J Endocrinol 212: 99-110.
36. Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV (2005). Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev 26: 171-202.
37. Rhodes ME, Li PK, Burke AM, Johnson DA (1997). Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res 773: 28-32.
38. Rhodes ME, Li PK, Flood JF, Johnson DA (1996). Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res 733: 284-286.
39. Risbrough V, Bontempi B, Menzaghi F (2002). Selective immunolesioning of the basal forebrain cholinergic neurons in rats: Effect on attention using the 5-choice serial reaction time task. Psychopharmacology (Berl) 164: 71-81.
40. Ritsner MS (2011). The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia. Neuroscience 191: 91-100.
41. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163: 362-380.
42. Robbins TW (2007). Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci 362: 917-932.
43. Robinson ES, Dalley JW, Theobald DE, Glennon JC, Pezze MA, Murphy ER et al (2008b). Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology 33: 2398-2406.
44. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X et al (2008a). Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33: 1028-1037.
45. Salum GA, Sergeant J, Sonuga-Barke E, Vandekerckhove J, Gadelha A, Pan PM et al (2014). Specificity of basic information processing and inhibitory control in attention deficit hyperactivity disorder. Psychol Med 44: 617-631, 1-15.
46. Solanto MV, Abikoff H, Sonuga-Barke E, Schachar R, Logan GD, Wigal T et al (2001). The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 29: 215-228.
47. Sonuga-Barke EJ, Sergeant JA, Nigg J, Willcutt E (2008). Executive dysfunction and delay aversion in attention deficit hyperactivity disorder: nosologic and diagnostic implications. Child Adolesc Psychiatr Clin N Am 17: 367-384.
48. Steckler T, Sahgal A (1995). The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res 67: 165-199.
49. Stergiakouli E, Langley K, Williams H, Walters J, Williams NM, Suren S et al (2011). Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder. Genes Brain Behav 10: 334-344.
50. Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD (1989). Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 17: 473-491.
51. Thapar A, O'Donovan M, Owen MJ (2005). The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 14(Suppl 2): R275-R282.
52. Trent S, Cassano T, Bedse G, Ojarikre OA, Humby T, Davies W (2012a). Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice. Neuropsychopharmacology 37: 1267-1274.
53. Trent S, Dean R, Veit B, Cassano T, Bedse G, Ojarikre OA et al (2013). Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder. Psychoneuroendocrinology 38: 1370-1380.
54. Trent S, Dennehy A, Richardson H, Ojarikre OA, Burgoyne PS, Humby T et al (2012b). Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder. Psychoneuroendocrinology 37: 221-229.
55. Trent S, Fry JP, Ojarikre OA, Davies W (2014). Altered brain gene expression but not steroid biochemistry in a genetic mouse model of neurodevelopmental disorder. Mol Autism 5: 21.
56. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW (2003). Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology 167: 304-314.